EUVIMEDEUVIMED entdecken
Open Access · CC BY-ND 4.0

Quality of life, distress, anxiety and depression of ambulatory cancer patients receiving chemotherapy

Aggeliki Papadopoulou, Ourania Govina, Ioanna Tsatsou, Marianna Mantzorou, Alexandra Mantoudi, Chrysoula Tsiou, Theodoula Adamakidou

Medicine and Pharmacy Reports · 18.10.2022 · 95 (4) · 418-429

DOI: 10.15386/mpr-2458 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medicine and Pharmacy Reports, online erschienen am 18.10.2022. Verfasst von Aggeliki Papadopoulou und 6 weiteren Autor:innen. Beteiligte Einrichtung: 417 NIMTS Army Veterans Hospital, Athens, Greece. Die Arbeit wurde bisher 42-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective and aim. Cancer and its treatment have substantial physical and psychological consequences that severely affect the patients’ quality of life (QoL) and emotional status. This study aimed to investigate the relationship between distress, anxiety, depression, and QoL of ambulatory cancer patients undergoing chemotherapy.

Methods

A descriptive, cross-sectional study of 150 cancer patients who were receiving chemotherapy in the outpatient unit of a central anticancer hospital in Athens. The data were collected through convenience sampling between November 2017 and January 2018, using a demographic and clinical characteristics questionnaire, the Distress Thermometer (DT) and Problem List (PL), the Hospital Anxiety and Depression Scale (HADS) and the European Organization for Research and Treatment for Cancer QoL assessment Questionnaire (EORTC QLQ-C30).

Results

Variability characterized the sample’s demographic and clinical characteristics. The majority of patients were women (64%), married (66%), high school graduates (43%), had breast cancer (35%), with a mean age of 60.07 ± 11.42. 83% reported anxiety, 75% reported fear, 51% nervousness and sadness, 34% depression and 84.7% fatigue. The DT was positively correlated with HADS (p

Schlagwörter

Stichwörter der Autor:innen

anxietycancer patientchemotherapydepressionquality of life

Autor:innen und Institutionen

  • 417 NIMTS Army Veterans Hospital, Athens, Greece.
  • Nursing Department, Postgraduate program "Neurological Disorders - Evidence Based Practice", University of West Attica, Athens, Greece.
  • Oncology-Hematology Department, Hellenic Airforce General Hospital, Athens, Greece.

Zitieren

APA

Papadopoulou, A., Govina, O., Tsatsou, I., Mantzorou, M., Mantoudi, A., Tsiou, C., & Adamakidou, T. (2022). Quality of life, distress, anxiety and depression of ambulatory cancer patients receiving chemotherapy. Medicine and Pharmacy Reports, 95(4), 418-429. https://doi.org/10.15386/mpr-2458

Vancouver

Papadopoulou A, Govina O, Tsatsou I, Mantzorou M, Mantoudi A, Tsiou C, et al. Quality of life, distress, anxiety and depression of ambulatory cancer patients receiving chemotherapy. Medicine and Pharmacy Reports. 2022;95(4):418-429. doi:10.15386/mpr-2458

BibTeX
@article{Papadopoulou2022,
  author = {Papadopoulou, Aggeliki and Govina, Ourania and Tsatsou, Ioanna and Mantzorou, Marianna and Mantoudi, Alexandra and Tsiou, Chrysoula and Adamakidou, Theodoula},
  title = {Quality of life, distress, anxiety and depression of ambulatory cancer patients receiving chemotherapy},
  journal = {Medicine and Pharmacy Reports},
  year = {2022},
  volume = {95},
  number = {4},
  pages = {418--429},
  doi = {10.15386/mpr-2458}
}
Kostenlos starten →